Stay updated on Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.

Latest updates to the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedPublication list descriptions were updated with minor wording clarifications, noting that PubMed-sourced publications are automatically filled and may not be about the study. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded references to the Moffitt Cancer Center and Research Institute and a 'Helpful Links Provided by' section. Removed a government funding status notice.SummaryDifference0.5%

- Check34 days agoChange DetectedCosmetic UI/layout adjustments and an updated last-updated timestamp were observed; core study content, eligibility, locations, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedMinimal change: added the labelSummaryDifference0.0%

- Check55 days agoChange DetectedAdded new dates (2025-10-10, 2025-09-30, 2025-09) and removed older dates (2025-08-11, 2025-07-31, 2025-07); overall, the page’s timeline has been updated to reflect more recent dates without changing core information.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.